This two-hour, online webinar provides Kentucky pharmacists and technicians with up-to-date information on medication for opioid use disorder (MOUD). The activity will provide a review of opioid use disorder (OUD), its diagnosis, and guideline recommendations. Learners will gain a better understanding of oral and injectable treatment options for OUD, including details on dosing, administration, precautions, and adverse effects. After completing this activity, learners will be able to compare MOUD options so that they may assist patients and other healthcare providers in selecting the most appropriate treatment modality as part of patient-centered care. This activity aims to help the pharmacy team understand their role in treating patients with OUD so that more patients will initiate and remain in treatment which will lead to improved long-term outcomes and reduced risk of opioid overdose in the community.
|
This ACPE-accredited continuing pharmacy education activity (UAN 0022-0000-23-010-H08-P/T) is designed to meet the Kentucky Board of Pharmacy continuing education regulatory requirement for pharmacists to complete CPE on the opioid epidemic or opioid use disorder as outlined in 201 KAR 2:015.
|
|---|
 Courtney V. Eatmon, PharmD, BCPP
Clinical Pharmacist Practitioner, Substance Use Disorders
Lexington Veterans Affairs Healthcare System
Lexington, Kentucky
|
|
| Dr. Courtney Eatmon received her PharmD from the University of Kentucky College of Pharmacy and completed a psychiatric pharmacy residency at the Lexington VA Healthcare System. She currently practices as a Board Certified Psychiatric Pharmacist in an outpatient substance use disorders clinic at the Lexington VA. As a credentialed prescriber, she manages a panel of patients, including those prescribed buprenorphine products for opioid use disorder. Her practice interests include expanding low-barrier care for substance use disorders, harm reduction, and treating co-occurring mental health conditions in veterans with substance use disorders. | |
|
Disclosure: Dr. Eatmon has no relevant financial relationships with ineligible companies to disclose.
|
|
 Tera McIntosh, PharmD, BCACP
Associate Professor
University of Kentucky College of Pharmacy
Lexington, Kentucky
|
|
|
Dr. Tera McIntosh is a clinical assistant professor of pharmacy practice and science at the University of Kentucky College of Pharmacy. She graduated from the University of Kentucky College of Pharmacy and completed a PGY1 community pharmacy residency at the University of Kentucky College of Pharmacy/American Pharmacy Services Corporation. Dr. McIntosh currently practices in an interprofessional ambulatory clinic at the Bluegrass Community Health Center (BCHC)—a Federally Qualified Health Center (FQHC) that is an accredited Patient Centered Medical Home (PCMH) with a focus on diabetes, hypertension, substance use disorders, and underserved populations. She received an Innovate Practice award for the patient care provided at BCHC from the Kentucky Pharmacist Association. She also practices at Capital Pharmacy and Medical Equipment, an independent community and long-term care pharmacy.
|
|
| Disclosure: Dr. McIntosh has no relevant financial relationships with ineligible companies to disclose. | |
|
Planners and Reviewers
The planners, organizers, and others in control of the content of this activity have no relevant financial relationships with ineligible companies to disclose.
|
|
ACPE Reviewer
Adrienne Matson, PharmD, BCPS
Disclosure: Dr. Matson has no relevant financial relationships with ineligible companies to disclose.
|
|
Peer Reviewer
Laura Stinson, PharmD
Disclosure: Dr. Stinson has no relevant financial relationships with ineligible companies to disclose.
|
Learning Objectives
Upon completion of this activity participants will be able to:
Pharmacists
- Describe the epidemiology of opioid use disorder (OUD) and its impact on public health.
- Identify key evidence from clinical trials to use when comparing treatment options and dosage forms of medications used to treat OUD.
- Outline the process of induction and maintenance in medications for opioid use disorder (MOUD).
- Discuss the role of pharmacists in different practice settings in management of OUD.
Pharmacy Technicians
- Describe opioid use disorder (OUD), its epidemiology, and impact on public health.
- List medications used for OUD and their different dosage forms.
- Recognize how chronic disease treatment applies to OUD.
- Discuss the role of the pharmacy technician in assisting with medications for opioid use disorder (MOUD).
Requirements for CE Credit
To claim credit for this activity, participants must:
1. Complete the pre-activity registration questionnaire
2. View the online video module in its entirety
3. Pass the post-test with a score of 70% or higher
4. Complete the activity evaluation
Upon successful completion participant CE credit will be directly uploaded to CPE Monitor.
Please be sure to verify your NABP e-Profile ID and date of birth (month/day) are correct under your learner profile in Learning Express before submitting your evaluation.
Fee
$0.00
CE Hours
2.00
CE Units
0.200
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists
- Pharmacy Technicians
Accreditation(s)
The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Support
This activity was supported by the National Institutes of Health through the NIH HEAL Initiative under award number UM1DA049406. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or its NIH HEAL Initiative. For more information regarding the NIH HEAL Initiative visit: NIH HEALing Communities Study and www.HealTogetherKY.org.
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, legal/regulatory issues and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities accredited by the University of Kentucky College of Pharmacy are intended solely for purposes of supplementing healthcare professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Kentucky College of Pharmacy.
For questions regarding this activity, please contact the UK CoP Continuing Professional Development Office at pharmacyCPD@uky.edu